Market Tracker

09/02 5:16pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

During the Trading Day
32.56 +0.79 / +2.49%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
32.56 0.00 / 0.00%
 
Volume: 9.8K

Today’s Trading

Previous close31.77
Today’s open32.09
Day’s range31.40 - 32.59
Volume838,318
Average volume (3 months)618,279
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-194.84%
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)+19.34%
P/E ratio135.4
Price/Sales4.33
Price/Book2.46

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+1.72+7.35%
ZSPHZS Pharma Inc+3.47+6.82%
HRTXHeron Therapeutics I...+1.37+3.83%
EBSEmergent BioSolution...+0.90+2.75%
Data as of 4:07pm ET, 09/02/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts